Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Luke Anschutz"'
Autor:
Davidson Matthew Gene, Sahra Niazi, Luke Anschutz, Cynthia Willson, Bradford Brabec, Patrick Burnett
Publikováno v:
Journal of Drugs in Dermatology. 20:70-75
Background This Phase 2, open-label study evaluated the safety, efficacy, systemic exposure, and impact on quality of life (QoL) with treatment using VP-102, a drug-device combination containing cantharidin (0.7% w/v) in subjects with molluscum conta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97f7c5d4412093d0e963313f4fec1141
https://doi.org/10.36849/jdd.5626
https://doi.org/10.36849/jdd.5626
Autor:
Joshua Fuller, Paul Wisman, Martin Levinson, Anthony Pruitt, Gary S. Marshall, Laurent Sigg, Regine Bataille, Luke Anschutz, Rogelio Amisola, Donald Hurley, Stephen Russell, Sean Livingston, John A. Fling, Julie Shepard, Shelly Senders, Paola Pirrotta, Mary Tipton, Michael Povey, Martin Schear, Alan Garscadden, James Hedrick, Dan Bi, Edward Zissman, Matthew Cornish, William Johnston, Armando Acevedo, Michael Leonardi, Remon Abu-Elyazeed, Leentje Moerman, Earl Franklin, David J. Hurley, Aarti Kulshrestha, Joseph B. Domachowske, Ana Ugarte, James D. Campbell, Peter E. Silas, Walter Rok, Nicola P. Klein, Tina Singh, Alvin Gabrielsen, Giancarlo Guido
Publikováno v:
Vaccine. 39(10)
Background In response to the detection of porcine circovirus type 1 (PCV-1) in the human rotavirus vaccine (HRV), a PCV-free HRV (no detection of PCV-1 and PCV-2 according to the detection limit of tests used) was developed. Liquid (Liq) PCV-free HR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9dbd5d2f8125a3c0dda967b9a5f0068
https://pubmed.ncbi.nlm.nih.gov/33077301
https://pubmed.ncbi.nlm.nih.gov/33077301